Related Experiment Videos
Hemorrhagic cardioembolic stroke: is anticoagulation absolutely contraindicated?
J F Brick1, J C Cheek, A R Gutierrez
1Department of Neurology, West Virginia University School of Medicine, Morgantown 26506.
Southern Medical Journal
|July 1, 1991
Summary
Hemorrhagic cerebral embolism may not rule out immediate low-dose anticoagulation. Careful, individualized treatment can protect against recurrent embolism while reducing bleeding risks, pending further research.
Area of Science:
- Neurology
- Vascular Neurology
- Neurosurgery
Background:
- Hemorrhagic cerebral embolism presents a complex clinical challenge.
- Systemic anticoagulation is often contraindicated due to bleeding risks.
Observation:
- Immediate low-dose systemic anticoagulation is being considered for patients with hemorrhagic cerebral embolism.
- Assessing the balance between preventing recurrent embolism and minimizing intracranial hemorrhage is critical.
Findings:
- Low levels of anticoagulation may offer protection against recurrent embolic events.
- This approach appears to minimize the risks associated with intracranial bleeding.
Implications:
- Hemorrhagic cerebral embolism may not be an absolute contraindication for anticoagulation.
- Case-by-case decisions are necessary due to limited scientific evidence.
- Further research is required to establish definitive guidelines for anticoagulation in these cases.